Elsevier

Journal of Cystic Fibrosis

Volume 6, Issue 6, 30 November 2007, Pages 403-410
Journal of Cystic Fibrosis

Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D3

https://doi.org/10.1016/j.jcf.2007.03.003Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

Antimicrobial peptides (AMPs) such as cathelicidins contribute to initial defense of the airway against inhaled pathogens. Recent studies have shown that the hormonally active form of vitamin D3, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) up-regulates AMP gene expression in several established cell lines. Furthermore, serum levels of vitamin D are often deficient in cystic fibrosis (CF) patients.

Methods

We investigated the effect of 1,25(OH)2D3 on AMP mRNA levels in primary cultures of normal human bronchial epithelial (NHBE) cells by real-time PCR, and protein levels by Western blot. Antimicrobial activity of airway surface fluid from these cells was measured by in vitro assay against laboratory strains of bacteria.

Results

Treatment of NHBE cells with 1,25(OH)2D3 (10- 8M), resulted in a 10-fold up-regulation of cathelicidin mRNA levels after 12 h, which was augmented 2-fold with co-incubation of 1 mM Calcium. Moreover, 1,25(OH)2D3 induced antimicrobial activity against the airway pathogens Bordetella bronchiseptica and Pseudomonas aeruginosa. 1,25(OH)2D3 induced cathelicidin mRNA expression equally in both normal and CF bronchial epithelial cells.

Conclusions

Elucidation of the effect of 1,25(OH)2D3 on cathelicidin expression in NHBE cells and CF bronchial epithelial cells will aid in the development of novel therapeutic agents for treatment of airway infections in CF.

Keywords

Innate immunity
Vitamin D
Antimicrobial peptide
Airway surface fluid

Cited by (0)